1. Taiwan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Norbel Baby Co., Ltd.

Norbel Baby Co., Ltd.

TTPEX:6844
55.30
TWD
0.00
(0.00%)
2.43BMarket Cap
Norbel Baby Co., Ltd.
TPEX:6844
(Taipei Exchange)

Recent

price

55.30

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
TWD
140.44
132.55
145.14
126.99
139.92
107.59
91.54
92.08
- -
Revenue per Share
13.33
9.2
10.05
8.79
12.08
6.21
3
2.35
- -
Basic EPS, GAAP
-4.11
13.83
5.84
8.73
19.6
12.22
5.75
7.69
- -
Free Cash Flow per Basic Share
10
5
4.99
5
7
10.47
6.14
5.1
- -
Dividend per Share
54.11
57.79
69.68
73.14
78.35
84.47
88.21
85.32
83.17
Book Value per Share
53.91
57.36
69.37
72.86
78.15
84.37
88.11
85.26
83.13
Tangible Book Value per Share
27
27
27
30
30
33
37
37
37
Basic Weighted Avg Shares
3,756
3,545
3,890
3,815
4,204
3,602
3,400
3,446
- -
Sales/Revenue/Turnover
11.84
9.08
8.95
8.59
10.75
6.91
3.56
2.2
- -
Operating Margin (%)
24
196
196
204
215
226
237
258
- -
Depreciation Expense
357
246
269
264
363
208
112
88
- -
Net Income, GAAP
21.91
22.73
20.95
21.23
19.99
20.05
19.71
13.08
- -
Effective Tax Rate (%)
9.49
6.94
6.92
6.93
8.63
5.78
3.28
2.55
- -
Profit Margin (%)
1,114
1,056
1,140
1,108
1,249
1,833
2,094
1,899
1,769
Working Capital
- -
721
670
689
780
807
860
990
1,064
LT Debt
1,626
1,736
2,093
2,197
2,354
2,960
3,302
3,193
3,113
Total Equity
- -
11.48
9.76
8.52
11.17
5.4
2.29
1.5
- -
Return on Invested Capital (%)
- -
12.15
10.2
9.26
11.77
6.08
3.02
2.42
- -
Return on Capital (%)
- -
14.64
14.07
12.32
15.95
7.83
3.56
2.71
- -
Return on Common Equity (%)

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
213
204
216
LT Borrowings
- -
- -
- -
LT Finance Leases
990
957
1,064
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
37
37
37
Market Capitalization
2,841
2,369
2,433

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,628
2,609
2,642
Cash, Cash Equivalents & STI
1,710
1,701
1,742
Accounts Receivable, Net
25
19
26
Inventories
834
839
824
Total Current Liabilities
729
820
874
Payables & Accruals
- -
- -
- -
ST Debt
213
204
216
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
9.22%
-3.28%
Free Cash Flow
- -
29.74%
34.9%
Net Income, GAAP
- -
-14.97%
-21.27%
Sales/Revenue/Turnover
- -
-2.06%
1.36%
Total Cash Common Dividend
- -
13.55%
-16.35%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
843
855
846
856
3,400
2025
871
862
- -
864
3,446
2026
849
857
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.74
0.73
0.68
0.85
3
2025
1.32
-0.23
- -
0.91
2.35
2026
1.57
0.46
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
6.14
2025
- -
- -
- -
- -
5.1
2026
- -
- -
- -
- -
- -
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Norbel Baby Co., Ltd. engages primarily in the pharmacy chain and channel business, offering professional pharmaceuticals, medical care products, health care items, women's and children's products, medical beauty products, and related consulting services through its branded stores, including Ding Ding Pharmacy or Tin Tin Drugstore. The company provides a broad range of maternity and infant products such as baby milk powder, diapers, and other baby essentials; health care drugs including nutritional supplements, health foods, and medications for children, adults, and seniors; health care products encompassing adult milk powder, adult diapers, medical equipment, and home living items; as well as cosmeceuticals, dietary supplements, and medical supplies. Norbel Baby operates approximately 94 large-scale professional chain pharmacies across Taiwan, employs around 776 staff including over 100 full-time pharmacists with an average of more than five years of experience, and primarily serves the Taiwan market with sales concentrated in maternity and infant products, medical supplies, and health foods totaling NT$3.4 billion in 2024. Founded in 1997 and headquartered at No. 87, Tachang 2nd Road, Sanmin District, Kaohsiung City, Taiwan, the company lists on the Taipei Exchange under ticker 6844. In recent developments, Qisda Corporation, which holds a significant stake, completed the acquisition of an additional 13.95% stake in Norbel Baby for approximately NT$910-913.5 million at NT$175 per share in November 2024 following a tender offer launched in September 2024, increasing its ownership from about 26.72% and strengthening strategic positioning in healthcare retail and elderly market opportunities.